Quick Answer
NEKTAR THERAPEUTICS reported Shares Outstanding of 20.38 million shares for fiscal year 2025.
NEKTAR THERAPEUTICS Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 20.38M | +64.5% |
| 2024 | 12.39M | -93.5% |
| 2023 | 191.38M | +1.5% |
| 2022 | 188.56M | +1.7% |
| 2021 | 185.47M | +3.0% |
| 2020 | 180.09M | +2.0% |
| 2019 | 176.50M | +1.7% |
| 2018 | 173.53M | +8.8% |
| 2017 | 159.52M | +4.1% |
| 2016 | 153.21M | +13.2% |
| 2015 | 135.29M | +3.1% |
| 2014 | 131.22M | +12.6% |
| 2013 | 116.49M | +1.1% |
| 2012 | 115.26M | +0.7% |
| 2011 | 114.48M | +21.1% |
| 2010 | 94.52M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 19.65M | -89.3% | +57.8% |
| June 30, 2025 | 12.46M | -93.2% | -93.3% |
| March 31, 2025 | 186.10M | +1.4% | +1402.6% |
| December 31, 2024 | 12.39M | -93.5% | -93.3% |
| September 30, 2024 | 184.46M | -3.3% | +0.2% |
| June 30, 2024 | 184.06M | -3.2% | +0.2% |
| March 31, 2024 | 183.62M | -3.0% | -4.1% |
| December 31, 2023 | 191.38M | +1.5% | +0.3% |
- NEKTAR THERAPEUTICS showed an increase of +64.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, NEKTAR THERAPEUTICS’s shares outstanding has declined by 78.4% (from 94.52 million shares to 20.38 million shares).
- The most recent figure is from NEKTAR THERAPEUTICS’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: